Published in Nutrients on September 23, 2015
Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies. BMC Med (2016) 0.83
Effects of Ready-to-Eat-Cereals on Key Nutritional and Health Outcomes: A Systematic Review. PLoS One (2016) 0.79
Homeostasis of chosen bioelements in organs of rats receiving lithium and/or selenium. Biometals (2016) 0.75
Is an Increase in Serum Magnesium One of the Causes of Cardiovascular Events Reduction in the EMPA-REG OUTCOME Study? J Clin Med Res (2017) 0.75
Serum Magnesium Concentration Is Inversely Associated with Albuminuria and Retinopathy among Patients with Diabetes. J Diabetes Res (2016) 0.75
Intravenous Magnesium Sulfate to Deliberate Hypotension and Bleeding after Bimaxillary Orthognathic Surgery; A Randomized Double-blind Controlled Trial. J Dent (Shiraz) (2016) 0.75
Cerebral vasospasm and wernicke encephalopathy secondary to adult cyclic vomiting syndrome: the role of magnesium. BMC Neurol (2016) 0.75
Acid sphingomyelinase/ceramide regulates carotid intima-media thickness in simulated weightless rats. Pflugers Arch (2017) 0.75
Role of magnesium supplementation in the treatment of depression: A randomized clinical trial. PLoS One (2017) 0.75
Continuous magnesium infusions in the management of systemic anti-cancer therapy-related hypomagnesaemia. Int J Clin Pharm (2017) 0.75
The diabetic brain and cognition. J Neural Transm (Vienna) (2017) 0.75
Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet (2002) 10.48
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med (2003) 4.04
Electrolyte and Acid-Base Disturbances in Patients with Diabetes Mellitus. N Engl J Med (2015) 3.96
Mechanisms of diabetic complications. Physiol Rev (2013) 3.41
Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) Lancet (1992) 3.40
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation (2010) 2.49
Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta (2000) 2.45
Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr (2013) 2.07
Magnesium intake and depression in adults. J Am Board Fam Med (2015) 2.04
Magnesium metabolism and its disorders. Clin Biochem Rev (2003) 2.00
Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies. Am J Clin Nutr (2011) 2.00
Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol (2007) 1.90
Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. JAMA (1989) 1.85
Frequency of hypomagnesemia and hypermagnesemia. Requested vs routine. JAMA (1990) 1.78
Magnesium: its proven and potential clinical significance. South Med J (2001) 1.77
MAGNESIUM METABOLISM IN HEALTH AND DISEASE. III. IN EXOPHTHALMIC GOITER, BASOPHILIC ADENOMA, ADDISON'S DISEASE AND STEATORRHEA. J Clin Invest (1937) 1.76
Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr (2012) 1.69
Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol (1995) 1.67
Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2. Clin Nephrol (2005) 1.67
Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med (2007) 1.65
Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care (2011) 1.63
Magnesium basics. Clin Kidney J (2012) 1.62
Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr (2013) 1.54
Impaired release of parathyroid hormone in magnesium deficiency. J Clin Endocrinol Metab (1976) 1.54
The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens (2002) 1.54
Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke (2009) 1.52
The link between lower serum magnesium and kidney function in patients with diabetes mellitus Type 2 deserves a closer look. Clin Nephrol (2009) 1.49
Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care (2005) 1.42
Recent developments in intestinal magnesium absorption. Curr Opin Gastroenterol (2008) 1.30
Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J (2010) 1.30
Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med (2015) 1.29
Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care (2010) 1.29
The epithelial Mg2+ channel transient receptor potential melastatin 6 is regulated by dietary Mg2+ content and estrogens. J Am Soc Nephrol (2006) 1.23
Comparative community genomics in the Dead Sea: an increasingly extreme environment. ISME J (2009) 1.19
Hypomagnesemia in patients in postoperative intensive care. Chest (1989) 1.16
Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res (2007) 1.14
Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst Rev (2006) 1.14
Magnesium, inflammation, and obesity in chronic disease. Nutr Rev (2010) 1.13
A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch Dis Child (2005) 1.09
What is the correct magnesium supplement? Magnes Res (2013) 1.08
Magnesium in drinking water and ischemic heart disease. Epidemiol Rev (1997) 1.08
Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab (2011) 1.07
Lowered magnesium in hypertension. Hypertension (2013) 1.07
Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res (1995) 1.05
Assessment of magnesium status for diagnosis and therapy. Magnes Res (2010) 1.05
Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr (2010) 1.04
Magnesium homeostasis and aging. Magnes Res (2009) 1.04
Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension (1993) 1.04
Complementary and alternative medicine for patients with chronic fatigue syndrome: a systematic review. BMC Complement Altern Med (2011) 1.03
Methods of assessment of magnesium status in humans: a systematic review. Magnes Res (2011) 1.02
Claudins of intestine and nephron - a correlation of molecular tight junction structure and barrier function. Acta Physiol (Oxf) (2011) 1.01
Magnesium in disease. Clin Kidney J (2012) 1.00
Regulation of magnesium balance: lessons learned from human genetic disease. Clin Kidney J (2012) 0.99
Magnesium in clinical medicine. Front Biosci (2004) 0.97
Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia (1996) 0.96
Magnesium and osteoporosis: current state of knowledge and future research directions. Nutrients (2013) 0.96
Magnesium, vitamin D status and mortality: results from US National Health and Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES III. BMC Med (2013) 0.96
Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure. J Card Fail (2007) 0.93
Gastrointestinal absorption and excretion of Mg 28 in man. Metabolism (1960) 0.92
Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension. Am J Hypertens (2009) 0.92
Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. II. Pervasive developmental disorder-autism. Magnes Res (2006) 0.92
Higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-aged americans. Diabetes Care (2013) 0.91
Magnesium VitB6 intake reduces central nervous system hyperexcitability in children. J Am Coll Nutr (2004) 0.90
Serum magnesium levels in the United States, 1971-1974. J Am Coll Nutr (1986) 0.90
Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnes Res (2008) 0.89
Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: a cross-sectional study. Nutr J (2012) 0.89
The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD). Positive response to magnesium oral loading test. Magnes Res (1997) 0.89
The relationship between magnesium and calciotropic hormones. Magnes Res (1995) 0.89
Antioxidant vitamins and magnesium and the risk of hearing loss in the US general population. Am J Clin Nutr (2013) 0.88
Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia (2002) 0.88
Magnesium and cardiovascular complications of chronic kidney disease. Nat Rev Nephrol (2015) 0.87
Altered ionized magnesium levels in mild-to-moderate Alzheimer's disease. Magnes Res (2011) 0.86
Effect of Mg2+ on Na(+)-dependent inositol transport. Role for Mg2+ in etiology of diabetic complications. Diabetes (1992) 0.86
Long term magnesium supplementation influences favourably the natural evolution of neuropathy in Mg-depleted type 1 diabetic patients (T1dm). Magnes Res (2004) 0.86
SERUM magnesium levels as an indicator of status of Diabetes Mellitus type 2. Diabetes Metab Syndr (2014) 0.86
Proton pump inhibitors and hypomagnesemia: a rare but serious complication. Kidney Int (2013) 0.86
Introduction: importance of Mg in physiology and medicine and the need for ion selective electrodes. Scand J Clin Lab Invest Suppl (1994) 0.85
Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache (1996) 0.85
Retracted Elevation of brain magnesium prevents and reverses cognitive deficits and synaptic loss in Alzheimer's disease mouse model. J Neurosci (2013) 0.83
Use of intravenous magnesium sulfate for the treatment of an acute asthma exacerbation in pediatric patients. J Pediatr Pharmacol Ther (2014) 0.83
Magnesium deficit ? overlooked cause of low vitamin D status? BMC Med (2013) 0.83
Magnesium depletion and pathogenesis of Alzheimer's disease. Magnes Res (1990) 0.83
Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study. Eur J Clin Invest (2008) 0.82
Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. I. Attention deficit hyperactivity disorders. Magnes Res (2006) 0.82
[Diagnostic value of examination of the magnesium homeostasis in children with attention deficit syndrome with hyperactivity]. Klin Lab Diagn (2005) 0.82
Association between intakes of magnesium, potassium, and calcium and risk of stroke: 2 cohorts of US women and updated meta-analyses. Am J Clin Nutr (2015) 0.81
[Interactions between drugs and micronutrients]. Med Monatsschr Pharm (2006) 0.81
Disturbances of magnesium concentrations in various brain areas in Alzheimer's disease. Magnes Res (2000) 0.81
Effects of magnesium and vitamin b6 on the severity of premenstrual syndrome symptoms. J Caring Sci (2012) 0.81
A pilot study on the effects of magnesium supplementation with high and low habitual dietary magnesium intake on resting and recovery from aerobic and resistance exercise and systolic blood pressure. J Sports Sci Med (2013) 0.80
Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain (2015) 0.80
Magnesium deficiency impairs fear conditioning in mice. Brain Res (2005) 0.80
About the misdiagnosis of magnesium deficiency. J Am Coll Nutr (2004) 0.79
[Effect of MAGNE-B6 on the clinical and biochemical manifestations of the syndrome of attention deficit and hyperactivity in children]. Eksp Klin Farmakol (2006) 0.79
The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for "normal" results. Clin Chem Lab Med (2010) 0.79
Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev (2005) 0.79
Oral magnesium supplementation improves borderline hypertension. Magnes Res (2011) 0.79
Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: relevance to atherogenesis, cardiovascular diseases and aging. Int J Clin Exp Med (2014) 0.79